VICKIE CLOUS: Open Payments
NPI 1588681324 · SAN TAN VALLEY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 28 payments from 14 companies in 2025. Trend: 2023 $643 · 2024 $745 · 2025 $558
Food & beverage: $558
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $106 |
| Novo Nordisk Inc | 5 | $97 |
| Phathom Pharmaceuticals, Inc. | 2 | $58 |
| Lilly USA, LLC | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| ABBVIE INC. | 2 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Optinose US, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: Veozah, VOQUEZNA, MOUNJARO, Wegovy, CAPLYTA, AIRSUPRA, QULIPTA, KEVEYIS.
Industry payments across AZ — which companies pay providers there.
